norfluoxetine has been researched along with Psychotic Disorders in 1 studies
norfluoxetine: metabolite of fluoxetine; RN given refers to parent cpd without isomeric designation
Psychotic Disorders: Disorders in which there is a loss of ego boundaries or a gross impairment in reality testing with delusions or prominent hallucinations. (From DSM-IV, 1994)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eap, CB | 1 |
| Bondolfi, G | 1 |
| Zullino, D | 1 |
| Savary-Cosendai, L | 1 |
| Powell-Golay, K | 1 |
| Kosel, M | 1 |
| Baumann, P | 1 |
1 trial available for norfluoxetine and Psychotic Disorders
| Article | Year |
|---|---|
Concentrations of the enantiomers of fluoxetine and norfluoxetine after multiple doses of fluoxetine in cytochrome P4502D6 poor and extensive metabolizers.
Topics: Adult; Antidepressive Agents, Second-Generation; Cytochrome P-450 CYP2D6; Dose-Response Relationship | 2001 |